Robert Nakayama

2.8k total citations
82 papers, 1.6k citations indexed

About

Robert Nakayama is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Robert Nakayama has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 34 papers in Rheumatology and 24 papers in Oncology. Recurrent topics in Robert Nakayama's work include Sarcoma Diagnosis and Treatment (58 papers), Bone Tumor Diagnosis and Treatments (24 papers) and Vascular Tumors and Angiosarcomas (14 papers). Robert Nakayama is often cited by papers focused on Sarcoma Diagnosis and Treatment (58 papers), Bone Tumor Diagnosis and Treatments (24 papers) and Vascular Tumors and Angiosarcomas (14 papers). Robert Nakayama collaborates with scholars based in Japan, United States and United Kingdom. Robert Nakayama's co-authors include Akira Kawai, Hideo Morioka, Yoshiaki Toyama, Tadashi Hasegawa, Eisuke Kobayashi, Hitoshi Ichikawa, Michiro Susa, Keisuke Horiuchi, Hiroo Yabe and Cigall Kadoch and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Robert Nakayama

75 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Nakayama Japan	21	829	697	496	303	268	82	1.6k
Tony Ng Canada	22	691 0.8×	938 1.3×	505 1.0×	413 1.4×	300 1.1×	57	2.2k
Hongying Zhang China	20	751 0.9×	402 0.6×	368 0.7×	323 1.1×	209 0.8×	83	1.3k
Johan Wejde Sweden	23	612 0.7×	587 0.8×	378 0.8×	374 1.2×	195 0.7×	47	1.5k
Yoshiyuki Suehara Japan	23	1.4k 1.7×	717 1.0×	863 1.7×	387 1.3×	244 0.9×	113	2.2k
Li-Xuan Qin United States	15	685 0.8×	525 0.8×	781 1.6×	162 0.5×	191 0.7×	19	1.5k
Hsuan-Ying Huang Taiwan	30	822 1.0×	1.2k 1.7×	700 1.4×	343 1.1×	274 1.0×	55	2.4k
Svetlana Bolshakov United States	22	738 0.9×	810 1.2×	609 1.2×	457 1.5×	334 1.2×	31	1.9k
Lorenzo D’Ambrosio Italy	18	777 0.9×	337 0.5×	590 1.2×	138 0.5×	171 0.6×	50	1.2k
Isidro Machado Spain	27	1.3k 1.6×	646 0.9×	741 1.5×	536 1.8×	417 1.6×	126	2.2k
Juan‐Miguel Mosquera United States	10	577 0.7×	374 0.5×	513 1.0×	367 1.2×	215 0.8×	11	1.3k

Countries citing papers authored by Robert Nakayama

Since Specialization

Citations

This map shows the geographic impact of Robert Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Nakayama more than expected).

Fields of papers citing papers by Robert Nakayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Nakayama. The network helps show where Robert Nakayama may publish in the future.

Co-authorship network of co-authors of Robert Nakayama

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Nakayama. A scholar is included among the top collaborators of Robert Nakayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Nakayama. Robert Nakayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsukushi, Satoshi, Kazuhiro Tanaka, Toshiyuki Kunisada, et al.. (2025). Clinicopathological background of local recurrence in high grade sarcoma of the extremity with preoperative chemotherapy: a supplementary analysis of JCOG0304. Japanese Journal of Clinical Oncology. 55(6). 603–609.

Asano, Naofumi, Hirohiko Totsuka, Sachiyo Mitani, et al.. (2024). Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma. Neoplasia. 59. 101074–101074.

Asano, Naofumi, Hiroshi Kobayashi, Tsukasa Yonemoto, et al.. (2024). Long-term functional outcome of limb-sparing surgery for paediatric bone sarcoma around the knee. Bone & Joint Open. 5(10). 868–878.

Tanaka, Kazuhiro, Ryunosuke Machida, Makoto Endo, et al.. (2024). Final results of a randomized phase II/III study comparing perioperative adriamycin plus ifosfamide and gemcitabine plus docetaxel for high-grade soft tissue sarcomas: Japan Clinical Oncology Group study JCOG1306.. Journal of Clinical Oncology. 42(16_suppl). 11503–11503. 1 indexed citations

Nakayama, Robert, Tomoaki Mori, Naofumi Asano, et al.. (2022). Recurrent malignant peripheral nerve sheath tumor presenting as an asymptomatic intravenous thrombus extending to the heart: a case report. World Journal of Surgical Oncology. 20(1). 2 indexed citations

Asano, Naofumi, Masato Saito, Eisuke Kobayashi, et al.. (2022). Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery. Annals of Surgical Oncology. 29(6). 3992–4000. 18 indexed citations

Masuda, Mari, Teppei Sugano, Naoko Goto, et al.. (2021). Direct conversion of osteosarcoma to adipocytes by targeting TNIK. JCI Insight. 6(3). 15 indexed citations

Tsuji, Osahiko, Satoshi Suzuki, Satoshi Nori, et al.. (2021). Cervical intramedullary recurrent Ewing sarcoma after 10-year disease-free survival in an adult: a case report and review of literature. Spinal Cord Series and Cases. 7(1). 45–45. 5 indexed citations

Urakawa, Hiroshi, Akira Kawai, Takahiro Goto, et al.. (2020). Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study. Cancer Science. 111(9). 3303–3312. 12 indexed citations

10.

Hori, Yumiko, Katsutoshi Hirose, Noriko Aramaki‐Hattori, et al.. (2020). Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway. Diagnostic Pathology. 15(1). 98–98. 19 indexed citations

11.

Yamaguchi, Sayaka, Naofumi Asano, Atsuhito Seki, et al.. (2019). Preservation of the Epiphysis and Growth Plate in the Surgical Management of Femoral Osteosarcoma in a Skeletally Immature Patient by Intercalary Resection and Biological Reconstruction: A Case Report. Case Reports in Oncology. 12(2). 513–522. 3 indexed citations

12.

Asano, Naofumi, Hideyuki Takeshima, Satoshi Yamashita, et al.. (2019). Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas. Scientific Reports. 9(1). 20360–20360. 17 indexed citations

13.

Saito, Masato, Kazumasa Nishimoto, Robert Nakayama, et al.. (2017). Extraskeletal Chondroma of the Index Finger: A Case Report. Case Reports in Oncology. 10(2). 479–484. 5 indexed citations

14.

Nakayama, Robert, Keisuke Horiuchi, Michiro Susa, et al.. (2014). Clinical Outcome after Bone Metastasis (BM) Surgery in Patients with Differentiated Thyroid Carcinoma (DTC): A Retrospective Study of 40 Cases. Japanese Journal of Clinical Oncology. 44(10). 918–925. 24 indexed citations

15.

Nakayama, Robert, Yasuhiro F. Miura, Jiro Ogino, et al.. (2012). Detection of HEY1‐NCOA2 fusion by fluorescence in‐situ hybridization in formalin‐fixed paraffin‐embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma. Pathology International. 62(12). 823–826. 33 indexed citations

16.

Kobayashi, Eisuke, Mari Masuda, Robert Nakayama, et al.. (2010). Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma. Molecular Cancer Therapeutics. 9(3). 535–544. 97 indexed citations

17.

Morii, Takeshi, Michiro Susa, Robert Nakayama, et al.. (2009). Reconstruction modality based on the spare part concept for massive soft tissue defects following oncological hemipelvectomy. Journal of Orthopaedic Science. 14(2). 192–197. 10 indexed citations

18.

Yamaguchi, Umio, Robert Nakayama, Kazufumi Honda, et al.. (2008). Distinct Gene Expression–Defined Classes of Gastrointestinal Stromal Tumor. Journal of Clinical Oncology. 26(25). 4100–4108. 97 indexed citations

19.

Horiuchi, Keisuke, Hideo Morioka, Kazumasa Nishimoto, et al.. (2008). Growth suppression and apoptosis induction in synovial sarcoma cell lines by a novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ). Cancer Letters. 272(2). 336–344. 9 indexed citations

20.

Kikuchi, Masao, Kenzo Sato, Yoshimasa Shiraishi, et al.. (1990). Constituents of Berchemia racemosa SIEB. et ZUCC.. YAKUGAKU ZASSHI. 110(5). 354–357. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact